glp-1 while nursing Medications Infographic Is GLP-1 therapy recommended during

doi: 10.1016/j.coph.2009.09.003

Calibrate Article published on October 1, 24 Medically reviewed by: Kristin Baier, MD Mounjaro (tirzepatide) and Ozempic (semaglutide): Both drug names have been trending lately, and maybe youre wondering why

Just start, one plate at a time

GLP-1 Pipeline In November 2023, the FDA approved Zepbound (tirzepatide), a GLP-1 antagonist and GIP dual agonist with superior weight loss efficacy compared to its competitors

Because it engages all three targets, it serves as a reference tool for research distinguishing triple-pathway activation from the dual GIP/GLP-1 mechanism characteristic of earlier-generation incretin compounds

No evidence of cardiac, hepatic, or renal toxicity, changes in serum lipids, or clinically relevant changes in laboratory parameters, vital signs, electrocardiograms, or abnormal findings upon physical examinations have been observed